Skip to main content

MARSHALL WACE, LLP

Position in PRTA — Prothena Corp Public Ltd Co

CIK 1318757 LONDON, X0

Position in PRTA

as of Jun 30, 2026 · filed Aug 13, 2026
Position Value
$1,868,263
+$1,435,005 QoQ
Shares Held
190,834
+328.1% QoQ
Ownership
0.372%
of shares outstanding
% of Portfolio
0.00%
of 13F equity value
Holder Rank
#39
of 187 holders
Holding Since
Dec 2020
11 quarters on record
Voting authority Sole 0% Shared 100% None 0%

Common Shares in PRTA Over Time

Shares Held

Position Value (USD)

Position in Biotechnology

Healthcare · as of Jun 30, 2026

MARSHALL WACE, LLP holds $3,014,740,742 across 267 Biotechnology names. PRTA ranks #144 (0.1% of the industry book) .

# Ticker Company Shares Value (USD) Open

All Filings in PRTA

Export CSV
11 filing rows on record
Report Date Value (USD) Shares
2026-06-30 $1,868,263 190,834
2026-03-31 $433,258 44,574
2025-12-31 $523,128 54,778
2023-06-30 $742,135 10,869
2022-09-30 $6,536,095 107,803
2022-06-30 $4,843,206 178,387
2022-03-31 $384,935 10,526
2021-12-31 $10,605,734 214,691
2021-09-30 $4,907,177 68,892
2021-03-31 $591,651 23,553
2020-12-31 $757,506 63,073